One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-123816
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 1 |
Affiliation: Dana-Farber Cancer Institute, Duke University, University of California, Davis, Ollscoil na Gaillimhe – University of Galway, Princess Alexandra Hospital, University Medical Center Groningen, University of Rochester, University Hospitals of Cleveland, The Ohio State University, University of Washington, Sir Charles Gairdner Hospital, IQVIA (United States), GlycoMimetics (United States), Cleveland Clinic, Fred Hutch Cancer CenterA Double-Blind, Placebo-Controlled, Phase 3 Registration Trial to Evaluate the Efficacy of Uproleselan (GMI-1271) with Standard Salvage Chemotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
